News
-
Indications and clinical value of Tirzepatide injection
Tirzepatide is a novel dual agonist of the GIP and GLP-1 receptors, approved for glycemic control in adults with type 2 diabetes as well as for long-term weight management in individuals with a bod...Read more -
Sermorelin Brings New Hope for Anti-Aging and Health Management
As global research into health and longevity continues to advance, a synthetic peptide known as Sermorelin is drawing increasing attention from both the medical community and the public. Unlike tra...Read more -
What is NAD+ and Why is It So Critical for Health and Longevity?
NAD⁺ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme present in nearly all living cells, often referred to as the “core molecule of cellular vitality.” It serves multiple roles in the ...Read more -
Semaglutide has attracted significant attention for its effectiveness in weight management
As a GLP-1 agonist, it mimics the physiological effects of naturally released GLP-1 in the body. In response to glucose intake, PPG neurons in the central nervous system (CNS) and L-cells in the gu...Read more -
Retatrutide: A Rising Star That Could Transform Obesity and Diabetes Treatment
In recent years, the rise of GLP-1 drugs such as semaglutide and tirzepatide has proven that significant weight loss is possible without surgery. Now, Retatrutide, a triple receptor agonist develop...Read more -
Tirzepatide Sparks a New Revolution in Weight Management, Offering Hope for People with Obesity
In recent years, global obesity rates have continued to rise, with related health issues becoming increasingly severe. Obesity not only affects appearance but also raises the risk of cardiovascular...Read more -
What exactly is the “peptide” that skin care product ingredients often talk about?
In recent years, “peptides” have become a buzzword across a wide range of health and wellness products. Favored by ingredient-savvy consumers, peptides have made their way from early haircare and s...Read more -
2025 Tirzepatide Market Trend
In 2025, Tirzepatide is experiencing rapid growth in the global metabolic disease treatment sector. With obesity and diabetes prevalence continuing to rise, and increasing public awareness of compr...Read more -
Semaglutide: The“Golden Molecule”Leading a New Era in Metabolic Therapies
As global obesity rates continue to rise and metabolic disorders become increasingly prevalent, Semaglutide has emerged as a focal point in both the pharmaceutical industry and capital markets. Wit...Read more -
The GLP-1 Boom Accelerates: Weight Loss Is Just the Beginning
In recent years, GLP-1 receptor agonists have rapidly expanded from diabetes treatments to mainstream weight management tools, becoming one of the most closely watched sectors in global pharmaceuti...Read more -
How Retatrutide Transforms Weight Loss
In today’s world, obesity has become a chronic condition affecting global health on a massive scale. It’s no longer just a matter of appearance—it poses serious threats to cardiovascular function, ...Read more -
Breaking the Bottleneck in Obesity and Diabetes Treatment: The Remarkable Efficacy of Tirzepatide.
Tirzepatide is a novel dual GIP/GLP-1 receptor agonist that has shown great promise in the treatment of metabolic diseases. By mimicking the actions of two natural incretin hormones, it enhances in...Read more